アスパラギナゼ治療の補助としてアスパラギンの摂取を制御するための食事の検討
Zara Forbrigger1, Tamara MacDonald2, Ketan Kulkarni2,3
1Department of Pathology, Dalhousie University, Halifax, NS, Canada.
Frontiers in oncology
|February 16, 2026
まとめ
ダイエットによるL-アスパラジン制限は,マウスの血中濃度を長期的に変化させなかった. 腸内細菌は変化したが,L-アスパラギナーゼは依然として血液のL-アスパラギンを枯渇させ,複雑な代謝制御を示唆した.
科学分野:
- バイオケミストリー バイオケミストリー
- 微生物学 微生物学とは
- 腫瘍学 腫瘍学
背景:
- L-アスパラギナゼは,小児急性リンパ性白血病の治療に不可欠です.
- L-アスパラギナゼは副作用があり,投与量の調整が必要になります.
- ダイエット,細胞,バクテリア合成はL-アスパラジンの源である.
研究 の 目的:
- L-アスパラジンの長期的食事制限がマウスの血液中のL-アスパラジンのレベルに影響するかどうかを調査する.
- 食事制限下でL-アスパラジン代謝における腸内細菌の役割を評価する.
主な方法:
- マウスは72日間,4%または0%のL-アスパラジンを含んだ食事を与えられました.
- 血液と糞便のサンプルを分析して,代謝産物やバクテリアを検出した.
- マウスはペギル化されたL-アスパラギナーゼを投与し,さらにサンプルを採取した.
主要な成果:
- どちらのダイエットも,一般的な健康状態や血液中のL-アスパラジンの基準値に影響を及ぼさなかった.
- ダイエットは腸内細菌の組成を変えたが,細菌のL-アスパラジン合成は変えない.
- L-アスパラギナゼは,両方のダイエットグループで,L-アスパラギンを効果的に血液を枯渇させた.
結論:
- マウスは,短期的なL-アスパラジンの食事の変化から回復し,複雑な代謝調節を示す.
- 腸内微生物は,この文脈で血液中のL-アスパラジンのレベルに有意な影響を及ぼすようには見えません.
- 血液中のL-アスパラジン源を特定するためにさらなる研究が必要です.
キーワード:
アスパラギネーゼ (asparaginase) とはアスパラギンはアスパラギンです.がん がん がん がん がん がん がんダイエットダイエット ダイエットダイエット白血病の白血病についてメタボローム メタボローム微生物群は,微生物の集合体である.さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
Chronic Kidney Disease III: Interprofessional Care
492
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
492
Allosteric Proteins-ATCase
6.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.6K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
12
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
12
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
1.1K
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.1K


